Respiratory viral infection: a potential “missing link” in the pathogenesis of COPD Dermot Linden, Hong Guo-Parke, Peter V. Coyle, Derek Fairley, Danny F. McAuley, Clifford C. Taggart, Joe Kidney Eur Respir Rev, 28 (151) 180063; 10.1183/16000617.0063-2018 | |
Women and COPD: do we need more evidence? Christophe Gut-Gobert, Arnaud Cavaillès, Adrien Dixmier, Stéphanie Guillot, Stéphane Jouneau, Christophe Leroyer, Sylvain Marchand-Adam, David Marquette, Jean-Claude Meurice, Nicolas Desvigne, Hugues Morel, Christine Person-Tacnet, Chantal Raherison Eur Respir Rev, 28 (151) 180055; 10.1183/16000617.0055-2018 | |
A systematic review of pharmacotherapeutic clinical trial end-points for bronchiectasis in adults Megan L. Crichton, Stefano Aliberti, James D. Chalmers Eur Respir Rev, 28 (151) 180108; 10.1183/16000617.0108-2018 | |
Prioritising children and adolescents in the tuberculosis response of the WHO European Region Matthias I. Gröschel, Martin van den Boom, Giovanni Battista Migliori, Masoud Dara Eur Respir Rev, 28 (151) 180106; 10.1183/16000617.0106-2018 | |
Fibrosing interstitial lung diseases: knowns and unknowns Vincent Cottin, Lutz Wollin, Aryeh Fischer, Manuel Quaresma, Susanne Stowasser, Sergio Harari Eur Respir Rev, 28 (151) 180100; 10.1183/16000617.0100-2018 | |
Receptor for advanced glycation end-products and environmental exposure related obstructive airways disease: a systematic review Syed H. Haider, Assad Oskuei, George Crowley, Sophia Kwon, Rachel Lam, Jessica Riggs, Mena Mikhail, Angela Talusan, Arul Veerappan, James S. Kim, Erin J. Caraher, Anna Nolan Eur Respir Rev, 28 (151) 180096; 10.1183/16000617.0096-2018 | |
Cancer-associated thrombosis: the when, how and why Caio J. Fernandes, Luciana T. K. Morinaga, José L. Alves, Marcela A. Castro, Daniela Calderaro, Carlos V. P. Jardim, Rogerio Souza Eur Respir Rev, 28 (151) 180119; 10.1183/16000617.0119-2018 | |